ANVS Annovis Bio Inc

Price (delayed)

$1.39

Market cap

$59.22M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.79

Enterprise value

$40.49M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 11
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 1

Headquartered in Malvern, Pennsylvania, Annovis Bio Inc. is dedicated to addressing neurodegeneration in diseases such as AD and PD. The company’s innovative approach targets multiple neurotoxic proteins, aiming to restore ...

Highlights
The quick ratio has soared by 166% since the previous quarter but it has dropped by 52% year-on-year
The EPS has grown by 10% year-on-year but it has declined by 4.7% since the previous quarter
ANVS's equity has dropped by 123% year-on-year
The net income has dropped by 64% year-on-year and by 21% since the previous quarter

Key stats

What are the main financial stats of ANVS

ANVS stock price

How has the Annovis Bio stock price performed over time
Intraday
-18.24%
1 week
-23.2%
1 month
-19.19%
1 year
-39.04%
YTD
-59.83%
QTD
-25.27%

Financial performance

How have Annovis Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$49.53M
Net income
-$49.52M
Gross margin
N/A
Net margin
N/A
The company's operating income has shrunk by 109% YoY and by 20% QoQ
The net income has dropped by 64% year-on-year and by 21% since the previous quarter

Price vs fundamentals

How does ANVS's price correlate with its fundamentals

Growth

What is Annovis Bio's growth rate over time

Valuation

What is Annovis Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 10% year-on-year but it has declined by 4.7% since the previous quarter
ANVS's equity has dropped by 123% year-on-year

Efficiency

How efficient is Annovis Bio business performance
The company's return on equity has shrunk by 116% QoQ
The return on assets has dropped by 63% year-on-year and by 20% since the previous quarter

Dividends

What is ANVS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANVS.

Financial health

How did Annovis Bio financials performed over time
Annovis Bio's total assets is 16% lower than its total liabilities
ANVS's current ratio has soared by 173% from the previous quarter but it has plunged by 55% YoY
The quick ratio has soared by 166% since the previous quarter but it has dropped by 52% year-on-year
The company's debt is 100% higher than its equity
ANVS's equity has dropped by 123% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.